nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acronyms and abbreviations
|
|
|
1997 |
30 |
4S3 |
p. S151- 1 p. |
artikel |
2 |
Acronyms and abbreviations
|
|
|
1997 |
30 |
4S3 |
p. S193- 1 p. |
artikel |
3 |
Errata
|
|
|
1997 |
30 |
4S3 |
p. iv- 1 p. |
artikel |
4 |
Foreword
|
Eknoyan, Garabed |
|
1997 |
30 |
4S3 |
p. S140-S141 2 p. |
artikel |
5 |
General acknowledgments
|
|
|
1997 |
30 |
4S3 |
p. S137- 1 p. |
artikel |
6 |
I. Anemia work-up
|
|
|
1997 |
30 |
4S3 |
p. S196-S198 3 p. |
artikel |
7 |
III. Iron support
|
|
|
1997 |
30 |
4S3 |
p. S202-S212 11 p. |
artikel |
8 |
III. Prevention of complications: Infection
|
|
|
1997 |
30 |
4S3 |
p. S167-S169 3 p. |
artikel |
9 |
II. Monitoring and maintenance
|
|
|
1997 |
30 |
4S3 |
p. S162-S166 5 p. |
artikel |
10 |
II. Target hematocrit/hemoglobin
|
|
|
1997 |
30 |
4S3 |
p. S199-S201 3 p. |
artikel |
11 |
Introduction
|
|
|
1997 |
30 |
4S3 |
p. S194-S195 2 p. |
artikel |
12 |
Introduction
|
|
|
1997 |
30 |
4S3 |
p. S152-S153 2 p. |
artikel |
13 |
I. Patient evaluation prior to access placement
|
|
|
1997 |
30 |
4S3 |
p. S154-S161 8 p. |
artikel |
14 |
IV. Administration of epoetin
|
|
|
1997 |
30 |
4S3 |
p. S213-S217 5 p. |
artikel |
15 |
IV. Management of complications: When to intervene
|
|
|
1997 |
30 |
4S3 |
p. S170-S172 3 p. |
artikel |
16 |
IX. References
|
|
|
1997 |
30 |
4S3 |
p. S227-S237 11 p. |
artikel |
17 |
NKF-DOQI Advisory council
|
|
|
1997 |
30 |
4S3 |
p. S138- 1 p. |
artikel |
18 |
NKF-DOQI co-chairs, NKF-DOQI vascular access work group membership, and Anemia work group membership
|
|
|
1997 |
30 |
4S3 |
p. S148-S149 2 p. |
artikel |
19 |
NKF-DOQI guideline development methodology
|
|
|
1997 |
30 |
4S3 |
p. S142-S147 6 p. |
artikel |
20 |
NKF-DOQI Steering committee
|
|
|
1997 |
30 |
4S3 |
p. S139- 1 p. |
artikel |
21 |
VIII. Biographical sketches of the NKF-DOQI vascular access work group members
|
|
|
1997 |
30 |
4S3 |
p. S190-S191 2 p. |
artikel |
22 |
VIII. Endnotes
|
|
|
1997 |
30 |
4S3 |
p. S224-S226 3 p. |
artikel |
23 |
VII. Possible adverse effects related to epoetin therapy
|
|
|
1997 |
30 |
4S3 |
p. S222-S223 2 p. |
artikel |
24 |
VII. References
|
|
|
1997 |
30 |
4S3 |
p. S184-S189 6 p. |
artikel |
25 |
V. Inadequate epoetin response
|
|
|
1997 |
30 |
4S3 |
p. S218-S220 3 p. |
artikel |
26 |
VI. Potential quality of care standards
|
|
|
1997 |
30 |
4S3 |
p. S179-S183 5 p. |
artikel |
27 |
VI. Role of red blood cell transfusions
|
|
|
1997 |
30 |
4S3 |
p. S221- 1 p. |
artikel |
28 |
V. Management of complications: Optimal approaches for treating complications
|
|
|
1997 |
30 |
4S3 |
p. S173-S178 6 p. |
artikel |
29 |
X. Biographical sketches of the NKF-DOQI anemia work group members
|
|
|
1997 |
30 |
4S3 |
p. S238-S240 3 p. |
artikel |